News
LISTEN HERE
 Jessica Goyder is the latest musician to put her singles on our site. Listen here
| THE INSIDER
 Get the lowdown inside the corridors of power in Oxfordshire here.
| SEND AN OBITUARY
Send us a tribute to someone who has passed away
| ON YER BIKE
 Get the view from the gutter with cycling group Cyclox in Oxfordshire
|
|
|
|
Another boost for Biomedica
OXFORD: Biotech firm Oxford Biomedica, based at the Oxford Science Park, has reported encouraging new data from a trial of its anti-cancer drug Trovax.
The product, which has already been successfully tested on kidney and bowel cancer, has produced positive results in its first Phase II trial with 27 prostate cancer patients.
Dr Mike McDonald, Oxford BioMedica's chief medical officer, said: "With our partner, Sanofi-aventis,we believe that TroVax could play an important role in the treatment ofprostate cancer, addressing a significant unmet need for patients."
2:02pm Tuesday 25th March 2008
Print 
Email this
What are these links for?
If you liked this article and would like to share it with others on the web who might be searching for good content we've made it easy for you to do it.
At the bottom of all articles, you'll see links to six sites. These sites - commonly called 'social bookmark' or 'social news' sites - have large communities of web users who share and rate interesting, useful and fun things on the web.
Clicking the links will automatically add the address of the story you are reading to one of these sites, letting you share it with others. Each site will ask you to register to share stories. Registration is free and once a member, you can store, recommend and search for stories that interest you.
More on Digg
More on del.icio.us
More on Furl
More on reddit
More on NowPublic/
More on Yahoo!
